Monday, 13 August 2018

Monsanto weedkiller case: Shares in German pharmaceutical group Bayer tumble after payout



Shares in German pharmaceutical group Bayer have dropped sharply following a US verdict linking a product to cancer.

 
By mid-morning on Monday, Bayer's shares had lost 10.4% of their value.


Bayer owns agriculture giant Monsanto - which was ordered by a California judge on Friday to pay $289m (£226m) damages to a man who said ingredients used in a weedkiller had caused his cancer.


Bayer says the product - glyphosate - is safe. It completed its $66bn takeover of Monsanto in June.





BBC                        News.